Advertisement

Topics

#news #biotech CRISPR CSO departs as Celgene continues to sell stock

08:47 EST 9 Feb 2018 | Biotech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CRISPR CSO departs as Celgene continues to sell stock .Bill Lundberg, M.D., has stepped down as CSO of CRISPR Therapeutics. News of Lundberg’s departure emerged on the same … Continue reading

Cet article #news #biotech CRISPR CSO departs as Celgene continues to sell stock est apparu en premier sur Biotech 365.

Original Article: #news #biotech CRISPR CSO departs as Celgene continues to sell stock

NEXT ARTICLE

More From BioPortfolio on "#news #biotech CRISPR CSO departs as Celgene continues to sell stock"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...